- SelecAll is a novel platform technology for creating stable and long-acting biologically based drugs using site specific bioconjugation technology

- PAT101 is a uniquely designed UOX protein conjugated to four (4) rhHSA protein molecules, generating a significantly enhanced PK profile with reduced immunogenicity.